EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) on Friday, soared 6.10% from the previous trading day, before settling in for the closing price of $16.72. Within the past 52 weeks, EYPT’s price has moved between $3.91 and $17.00.
Annual sales at Healthcare sector company grew by 15.65% over the past five years. The company achieved an average annual earnings per share of -30.72%. With a float of $71.37 million, this company’s outstanding shares have now reached $82.79 million.
EyePoint Pharmaceuticals Inc (EYPT) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of EyePoint Pharmaceuticals Inc is 13.79%, while institutional ownership is 74.76%. The most recent insider transaction that took place on Dec 04 ’25, was worth 140,477. In this transaction Director of this company sold 9,300 shares at a rate of $15.11, taking the stock ownership to the 206,547 shares. Before that another transaction happened on Dec 04 ’25, when Company’s Officer proposed sale 9,300 for $15.11, making the entire transaction worth $140,477.
EyePoint Pharmaceuticals Inc (EYPT) Performance Highlights and Predictions
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.64 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.48) by -0.16. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.67 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -30.72% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -4.04% during the next five years compared to 15.65% growth over the previous five years of trading.
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) Trading Performance Indicators
EyePoint Pharmaceuticals Inc (EYPT) is currently performing well based on its current performance indicators. A quick ratio of 7.11 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 34.69.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.99, a number that is poised to hit -0.75 in the next quarter and is forecasted to reach -2.87 in one year’s time.
Technical Analysis of EyePoint Pharmaceuticals Inc (EYPT)
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) saw its 5-day average volume 1.15 million, a positive change from its year-to-date volume of 0.93 million. As of the previous 9 days, the stock’s Stochastic %D was 87.20%.
During the past 100 days, EyePoint Pharmaceuticals Inc’s (EYPT) raw stochastic average was set at 99.05%, which indicates a significant increase from 98.72% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.04 in the past 14 days, which was higher than the 0.81 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $13.06, while its 200-day Moving Average is $9.73. Nevertheless, the first resistance level for the watch stands at $18.18 in the near term. At $18.61, the stock is likely to face the second major resistance level. The third major resistance level sits at $19.41. If the price goes on to break the first support level at $16.95, it is likely to go to the next support level at $16.15. Assuming the price breaks the second support level, the third support level stands at $15.72.
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) Key Stats
Market capitalization of the company is 1.47 billion based on 82,787K outstanding shares. Right now, sales total 43,270 K and income totals -130,870 K. The company made 970 K in profit during its latest quarter, and -59,730 K in sales during its previous quarter.
